A Year Of Change: Looking Back At Francis’ First Year At Teva
Teva’s CEO, In Charge For A Year, Has Laid Clear Its More Innovative Ambitions
As part of a Generics Bulletin series focusing on some of the industry’s biggest players, we look at the changing landscape at Teva in 2023, spearheaded by the appointment of its CEO Richard Francis.
